Certified Quality & 2-Year Warranty: This brain injury screening kit holds official CE and ISO 13485 medical certifications for global compliance and comes backed by a comprehensive 2-year factory performance warranty to mitigate commercial inventory risk.
Advanced Fluorescence Technology: Utilizing highly sensitive fluorescence immunochromatography (FIA), the kit captures subtle central nervous system damage signals down to pg/mL levels, providing precise quantitative results within 15 minutes to effectively guide emergency triage and reduce unnecessary CT scans.
Product Introduction Copy (Marketing Copy)
["Biochemical Radar for Early Diagnosis of Brain Injuries - A Rapid and Quantitative Central Nervous System Assessment Solution"]
The S100-β protein is one of the most sensitive biochemical indicators reflecting the degree of damage to the central nervous system, and is hailed as the "biochemical marker" of brain injury. (Guogao Biotech) The S100-β protein detection kit uses a highly sensitive fluorescence immunochromatography technology (FIA) and is specifically designed as a POCT solution for emergency departments, neurosurgery, ICU, and neurology departments.
Core Strengths
Early Risk Warning: After mild traumatic brain injury (TBI) or stroke occurs, the level of S100-β rapidly increases, which can indicate brain tissue damage earlier than imaging examinations, effectively assisting in emergency triage.
Assessing the Degree of Injury and Prognosis: The concentration level is positively correlated with the extent of brain injury and prognosis. Through dynamic quantitative detection, it helps doctors assess the treatment effect and the recovery of neurological function.
Leading Fluorescence Method Technology: Compared with the colloidal gold method, fluorescence immunoassay has higher sensitivity (up to pg/mL level) and a wider linear range, capable of capturing extremely subtle signals of brain tissue damage.
Reducing Unnecessary CT Scans: Combined with clinical assessment, negative results can serve as a reference for low-risk patients not needing head CT scans, optimizing the utilization of medical resources.
POCT Simple Process: A quantitative report is issued within 15 minutes, supporting whole blood, serum, and plasma samples. Equipped with a dedicated fluorescence immunoassay analyzer from Guo Gao Biotechnology, it enables automated reading.
Product Specifications
| Brand | Guogao Biotech |
| Product Name | S100-β Protein Assay Kit |
| Methodology | Fluorescence Immunochromatography |
| Test Type | Quantitative Determination |
| Clinical Use | Auxiliary diagnosis of brain injury (TBI), Stroke assessment, Cerebral hypoxia monitoring, Neurosurgical procedure monitoring |
| Specimen | Serum / Plasma / Whole Blood |
| Linear Range | Typically 0.05 μg/L – 5.0 μg/L (Refer to the instrument specifications for details) |
| Reaction Time | 10 – 15 minutes |
| Storage | 2°C – 30°C (Store in a cool, dry place away from light) |
| Shelf Life | 24 months |
| Packaging | 25 tests/kit |
| Compatibility | Requires a dedicated Guogao Biotech fluorescence immunoassay analyzer for result reading |
Place of Origin: |
China,Hebei |
Brand Name: |
GuoGao |
Model Number: |
S100 |
Certification: |
CE ISO13485 |
The Factory Wholesale Two Year Warranty Analyzer Compatible Quantitative Brain Injury Screening S100B Test Kit by Beijing Jiachuang Jiuhe Global Trade Co., Ltd is an elite in vitro diagnostic solution engineered for rapid neurological assessment. Operating as a highly specialized S100B test kit, this advanced panel provides immediate, accurate detection of the S100B protein, a proven biochemical marker for central nervous system damage. This analyzer compatible S100B diagnostic tool delivers rapid, actionable quantitative results to assist clinicians in evaluating concussions and mild traumatic brain injuries. Backed by a comprehensive two-year factory warranty, this premium brain injury screening kit streamlines clinical triage workflows, helping healthcare facilities reduce unnecessary head CT scans while maintaining uncompromising patient care standards.
In the fast-paced realm of emergency medicine and neurocritical care, managing traumatic brain injury (TBI) demands immediate and definitive objective data. The Quantitative S100B Assay fills a critical diagnostic gap by serving as an early neurochemical warning system. S100B is a calcium-binding protein concentrated heavily in central nervous system astrocytes. Following physical head trauma or ischemic neurological injury, this cellular protein leaks across the disrupted blood-brain barrier into systemic circulation, making a targeted S100B test kit the ideal tool for blood-based molecular screening.
Quantitative Analytical Precision: Delivers highly accurate numerical readouts that map directly to the severity of structural astrocytic damage.
Universal Analyzer Compatibility: Engineered as an analyzer compatible S100B cassette system that easily integrates with standard laboratory fluorescence immunoassay setups.
Two-Year Factory Warranty: Guarantees product performance, batch consistency, and reagent shelf stability, reflecting our absolute commitment to manufacturing excellence.
Rapid Clinical Turnaround: Provides crucial data within minutes, allowing emergency teams to perform efficient cardiorespiratory and neurological triage.
High Negative Predictive Value: Offers a powerful clinical screening threshold to confidently rule out intracranial bleeding without immediate CT scanning.
| Parameter Item | Specification Details |
| Product Name | Quantitative S100B Brain Injury Screening Kit |
| Primary Biomarker | S100B Protein (Astrocytic Marker) |
| Methodology | Time-Resolved Fluorescence Immunochromatography |
| Compatibility | Fully Analyzer Compatible S100B System |
| Warranty Coverage | 2-Year Factory Performance Guarantee |
| Sample Requirements | Serum, Plasma, or Whole Blood |
| Storage Temperature | 2°C – 30°C Ambient Stability |
| Packaging Unit | Professional B2B Bulk / Wholesale Packaging |
Standard physical evaluation scores, such as the Glasgow Coma Scale (GCS), frequently struggle to identify underlying microstructural micro-hemorrhages or diffuse axonal injuries in alert patients. Our Quantitative S100B Assay eliminates this ambiguity by tracking a definitive traumatic brain injury biomarker. Because S100B has a short biological half-life of approximately 90 minutes, its concentration in the bloodstream serves as a real-time molecular mirror of active central nervous system distress and cellular degradation.
The analytical sensitivity of this S100B test kit is finely tuned to ensure a minimal limit of detection ($LoD \le 0.05\ \text{ng/mL}$), ensuring that even minor concussive events generate detectable kinetic shifts. Furthermore, our advanced antibody pairing methodology effectively eliminates cross-reactivity with peripheral S100A proteins found in adipose or muscle tissues. This rigorous design guarantees an exceptionally high specificity profile, enabling trauma teams to confidently distinguish true intracranial injury from simple extracranial soft tissue lacerations.
Hospital Emergency Departments: Serving as an objective, frontline screening filter to optimize the utilization of cranial computed tomography (CT) imaging.
Sports Medicine & Urgent Care: Providing rapid, field-adjacent evaluation for athletes suspected of experiencing concussions or mild traumatic injuries.
Intensive Care Units (ICUs): Continuous monitoring of severe TBI patients to track the potential onset of secondary brain swelling or ischemic events.
Military & First Responder Triage: Acting as a ruggedized, deployable wholesale brain injury test solution for remote field diagnostics and mass casualty management.
Securing bulk procurement channels for the S100B test kit from Beijing Jiachuang Jiuhe Global Trade Co., Ltd offers major commercial leverage:
Untapped High-Growth Market: Capture significant market share as global healthcare guidelines increasingly implement blood-based biomarkers for routine concussion protocols.
Mitigated Commercial Risk: Our factory-backed two-year warranty protects your wholesale inventory against unexpected losses, building immense trust across your local supply chains.
A: Qualitative tests only show a positive or negative result, which is insufficient for neurological monitoring. A quantitative S100B assay provides exact numerical values, allowing physicians to track whether a brain injury is stabilizing or worsening over time.
A: This kit is designed to be an analyzer compatible S100B tool. It integrates perfectly with our company's proprietary closed systems as well as various standardized open fluorescence immunoassay platforms used globally.
Certified Quality & 2-Year Warranty: This brain injury screening kit holds official CE and ISO 13485 medical certifications for global compliance and comes backed by a comprehensive 2-year factory performance warranty to mitigate commercial inventory risk.
Advanced Fluorescence Technology: Utilizing highly sensitive fluorescence immunochromatography (FIA), the kit captures subtle central nervous system damage signals down to pg/mL levels, providing precise quantitative results within 15 minutes to effectively guide emergency triage and reduce unnecessary CT scans.
EN